Results 91 to 100 of about 414,143 (313)

The Dynamics of Neurofilament Light Chain in Spinal Muscular Atrophy

Annals of Neurology, EarlyView.
Objective Newborn screening (NBS) for spinal muscular atrophy (SMA) facilitates early diagnosis and treatment for affected individuals. However, fluid biomarkers that provide early insights into disease activity and outcomes in a neonatal cohort and those unable to access (due to reimbursement criteria) or deferring immediate treatment are lacking ...
Arlene D'Silva, Karen Herbert, Lakshmi Balaji, Jia Mei He, Tejaswi Kandula, Hugo A. Sampaio, Hooi‐Ling Teoh, Esther Tantsis, Jihee Sohn, Nancy Briggs, Nickson Ning, Matthew C. Kiernan, Didu S. Kariyawasam, Michelle A. Farrar   +13 more
wiley   +1 more source

The Value of Fixed-Reimbursement Healthcare Insurance- Evidence from Cancer Patients in Ontario, Canada [PDF]

Critical illness insurance (CII) is a fixed-reimbursement scheme conditioned on the event of a loss, not the size of the loss. We investigate demand for CII. Consumers will be willing to purchase CII depending on their degree of risk aversion to the cost
Christopher Longo, Michel Grignon
core  

The emerging landscape of reimbursement of regenerative medicine products in the UK: publications, policies and politics [PDF]

, 2017
Aims This paper aims to map the trends and analyse key institutional dynamics that are constituting the policies for reimbursement of Regenerative Medicine (RM), especially in the UK.
Alex Faulkner, Aurélie Mahalatchimy, Campillo-Artero C, Gerke S   +3 more
core   +3 more sources

Reimbursement and the Practice of Cardiology

Journal of the American College of Cardiology, 2012
To offer a German perspective on reimbursement and its impact on cardiology practice, key features of the current system in Germany are presented. Changes in the way cardiology is practiced and reimbursed in the United States—real and anticipated—have created frustrations and concerns ...
Flachskampf, Frank A., von Erffa, Johannes, Seligmann, Christian   +2 more
openaire   +2 more sources

Reimbursing Preventive Care [PDF]

The Geneva Papers on Risk and Insurance Theory, 2004
The paper focus on secondary prevention (diagnostic screening, medical examination, chech-up…) which refers to the early detection of disese. In particular secondary prevention in analyzed as an instrument of self-isurance: if illness occurs, the negative health shock decrease. Both the case in which secondary prevention and treatment are complementary
openaire   +4 more sources

Older, Starting, and Pitchers With Greater Increase in Pitch Pace Experience Elevated Injury Risk Following Pitch Clock Implementation

Arthroscopy, EarlyView.
Purpose To identify risk factors for pitcher injury during the 2023 inaugural pitch clock season and evaluate the relationship between pitcher injuries and changes in pitch pace between the 2022 and 2023 seasons. Methods Pitchers were included for analysis if they had ≥70 pitches recorded in the Major League Baseball Statcast dataset, in the 2022 and ...
Cody C. Ashy, Henry B. G. Baird, Steven Gannon, Gregory D. Myer, W. Michael Pullen, Harris S. Slone   +5 more
wiley   +1 more source

Comments to “Cost per responder for vedolizumab and ustekinumab in Crohn’s disease patients after failure of TNF-α inhibitors in Italy”

AboutOpen, 2023
Ottavio Secchi, Andrea Franchi, Armando Lunello   +2 more
doaj   +1 more source

Shaping national rare diseases definition in Saudi Arabia: outcome from health ecosystem multisectoral workshop

Frontiers in Pharmacology
IntroductionRare diseases are characterized by low prevalence, a profound impact on patients, and significant challenges in accessing treatment. In Saudi Arabia, the absence of an official definition hampers policymaking, resource allocation, and orphan ...
Ghada Mohammed Abozaid, Ghada Mohammed Abozaid, Hussain Abdulrahman Al-Omar, Abdulaziz Alrabiah, Hiba Alomary, Amy Jayne McKnight   +5 more
doaj   +1 more source

Do Pharmaceutical Prices Respond to Insurance? [PDF]

Despite the importance of patient insurance in the market for prescription pharmaceuticals, little is known about the impact of insurance on the pricing behavior of pharmaceutical firms.
Nina Pavcnik
core  

The implications of “pay-for-performance” reimbursement for Otolaryngology – Head and Neck Surgery [PDF]

, 2005
Objective: To introduce otolaryngologists to outcomes-linked reimbursement ( pay-for-performance ), identify clinical practice implications and recommend changes for successful transition from the traditional pay-for-effort reimbursement model.
Benko LB, Colwell J., Doherty RB, Epstein AM, Glendenning D., Gosfield AG, Henley E., Institute of Medicine, Kohn KT, Leape LL, O'Reilly KB, Schneider ME, Shah RK, Sipkoff M., Terry K.   +14 more
core   +2 more sources